Gorlin syndrome: Evaluating the burden of disease in 50 patients seen in a private dermatology group Mendeley Supplements 1 and 2

Published: 20 October 2021| Version 1 | DOI: 10.17632/m6893sbt4b.1
Contributors:
,
,
,
,

Description

Supplement 1 is an explanation of burden score calculation. Supplement 2 is the number of patients and private group dermatology practice office locations by region.

Files

Steps to reproduce

For supplement 1: Each patient was assigned a disease burden score, a metric designed to numerically quantify the overall disease burden experienced by each individual patient. More information is included in the supplement. For supplement 2: The data was gathered by obtaining the number of Advanced Dermatology and Cosmetic Surgery Clinics around the nation separated by region, number of patients out of the 50 Gorlin Syndrome patients, number of group practice offices, and the number of Gorlin Syndrome patients per group practice office.

Institutions

ADCS Clinics LLC, Ameriderm Research, University of Central Florida

Categories

Congenital Disorder, Basal Cell Carcinoma, Disease Burden

License